Reactivation and role of HHV-8 in Kaposi's sarcoma initiation

2001 ◽  
pp. 161-200 ◽  
Author(s):  
Barbara Ensoli ◽  
Michael Stürzl ◽  
Paolo Monini
2009 ◽  
Vol 83 (9) ◽  
pp. 4326-4337 ◽  
Author(s):  
Brenna Kelley-Clarke ◽  
Erika De Leon-Vazquez ◽  
Katherine Slain ◽  
Andrew J. Barbera ◽  
Kenneth M. Kaye

ABSTRACT Kaposi's sarcoma-associated herpesvirus (KSHV) LANA is an 1,162-amino-acid protein that tethers terminal repeat (TR) DNA to mitotic chromosomes to mediate episome persistence in dividing cells. C-terminal LANA self-associates to bind TR DNA. LANA contains independent N- and C-terminal chromosome binding regions. N-terminal LANA binds histones H2A/H2B to attach to chromosomes, and this binding is essential for episome persistence. We now investigate the role of C-terminal chromosome binding in LANA function. Alanine substitutions for LANA residues 1068LKK1070 and 1125SHP1127 severely impaired chromosome binding but did not reduce the other C-terminal LANA functions of self-association or DNA binding. The 1068LKK1070 and 1125SHP1127 substitutions did not reduce LANA's inhibition of RB1-induced growth arrest, transactivation of the CDK2 promoter, or C-terminal LANA's inhibition of p53 activation of the BAX promoter. When N-terminal LANA was wild type, the 1068LKK1070 and 1125SHP1127 substitutions also did not reduce LANA chromosome association or episome persistence. However, when N-terminal LANA binding to chromosomes was modestly diminished, the substitutions in 1068LKK1070 and 1125SHP1127 dramatically reduced both LANA chromosome association and episome persistence. These data suggest a model in which N- and C-terminal LANA cooperatively associates with chromosomes to mediate full-length LANA chromosome binding and viral persistence.


1998 ◽  
Vol 65 (12) ◽  
pp. S149
Author(s):  
A. T??th ◽  
J. J??ray ◽  
D. G??r??g ◽  
K. Nagy ◽  
B. Szende ◽  
...  

2009 ◽  
Vol 95 (3) ◽  
pp. 325-328 ◽  
Author(s):  
Stefano Pergolizzi ◽  
Anna Santacaterina ◽  
Michele Gaeta ◽  
Alfredo Blandino

Purpose To describe the clinical outcome and to evaluate the role of orthovoltage radiotherapy in the treatment of young (less than 30 years old) Mediterranean men with Kaposi's sarcoma. Patients and methods We reviewed the records of 198 consecutive patients with Kaposi's sarcoma treated with orthovoltage radiation therapy at our department between January 1920 and December 1987. Result We found three young shepherds, aged less than 30 years, with an available follow-up ranging from 45 to 67 years. One patient died at the age of 84 years of chronic renal failure while suffering from cutaneous Kaposi's sarcoma; two patients are still alive with recurrent Kaposi's sarcoma. Conclusions We presume that an indolent form of Kaposi's sarcoma may occur in young men. This very indolent form can be controlled for the duration of the patient's life by judiciously applied radiation therapy.


Viruses ◽  
2014 ◽  
Vol 6 (11) ◽  
pp. 4571-4580 ◽  
Author(s):  
Zhiqiang Qin ◽  
Francesca Peruzzi ◽  
Krzysztof Reiss ◽  
Lu Dai

Dermatology ◽  
1998 ◽  
Vol 196 (4) ◽  
pp. 447-449 ◽  
Author(s):  
T. Simonart ◽  
J.C. Noel ◽  
J.P. van Vooren ◽  
D. Parent

2003 ◽  
Vol 279 (6) ◽  
pp. 4136-4143 ◽  
Author(s):  
Stefano Buttiglieri ◽  
Maria Chiara Deregibus ◽  
Stefania Bravo ◽  
Paola Cassoni ◽  
Roberto Chiarle ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document